PSS31 - COST PER RESPONDER OF SECUKINUMAB COMPARED TO OTHER BIOLOGICS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
Abstract
Authors
C. Suzuki N. Lopes I. Gilloteau C. Graham
C. Suzuki N. Lopes I. Gilloteau C. Graham
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now